{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:19:18Z","timestamp":1788985158392,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lithium (Li) is a well-established mood disorder treatment and may be neuroprotective. Bi-directional regulation (i.e. affecting manic symptoms and depressive symptoms) by Li has not been demonstrated. This study explored: (1) bidirectional regulation by Li in murine models of depression, mania, and bipolar disorder (BP); and (2) potential Li synergism with antidepressant\/anti-mania agents. The chronic unpredictable mild stress (CUMS) and ketamine-induced mania (KM) models were used. These methods were used in series to produce a BP model. In vivo two-photon imaging was used to visualize Ca<jats:sup>2+<\/jats:sup> activity in the dorsolateral prefrontal cortex. Depressiveness, mania, and cognitive function were assessed with the forced swim task (FST), open field activity (OFA) task, and novel object recognition task, respectively. In CUMS mice, Ca<jats:sup>2+<\/jats:sup> activity was increased strongly by Li and weakly by lamotrigine (LTG) or valproate (VPA), and LTG co-administration reduced Li and VPA monotherapy effects; depressive immobility in the FST was attenuated by Li or LTG, and attenuated more strongly by LTG-VPA or LTG-Li; novel object exploration was increased strongly by Li and weakly by LTG-Li, and reduced by LTG, VPA, or LTG-VPA. In KM mice, Li or VPA attenuated OFA mania symptoms and normalized Ca<jats:sup>2+<\/jats:sup> activity partially; Li improved cognitive function while VPA exacerbated the KM alteration. These patterns were replicated in the respective BP model phases. Lithium had bi-directional, albeit weak, mood regulation effects and a cognitive supporting effect. Li co-administration with antidepressant\/-manic agents enhanced mood-regulatory efficacy while attenuating their cognitive-impairing effects.<\/jats:p>","DOI":"10.1038\/s41398-022-02087-6","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T08:03:38Z","timestamp":1662105818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive\/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-550X","authenticated-orcid":false,"given":"Chuanjun","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9679-2273","authenticated-orcid":false,"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9830-7155","authenticated-orcid":false,"given":"Xueqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"2087_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1001\/jamapsychiatry.2021.3170","volume":"79","author":"IR Katz","year":"2022","unstructured":"Katz IR, Rogers MP, Lew R, Thwin SS, Doros G, Ahearn E, et al. Lithium treatment in the prevention of repeat suicide-related outcomes in veterans with major depression or bipolar disorder: a Randomized Clinical Trial. JAMA Psychiatry. 2022;79:24\u201332. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.3170","journal-title":"JAMA Psychiatry"},{"key":"2087_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/acps.13346","volume":"144","author":"CW Hsu","year":"2021","unstructured":"Hsu CW, Carvalho AF, Tsai SY, Wang LJ, Tseng PT, Lin PY, et al. Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: Multicenter cohort and meta-analysis. Acta Psychiatr Scand. 2021;144:368\u201378. https:\/\/doi.org\/10.1111\/acps.13346","journal-title":"Acta Psychiatr Scand."},{"key":"2087_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/acps.13277","volume":"143","author":"S Lambrichts","year":"2021","unstructured":"Lambrichts S, Detraux J, Vansteelandt K, Nordenskj\u00f6ld A, Obbels J, Schrijvers D, et al. Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta-analysis. Acta Psychiatr Scand. 2021;143:294\u2013306. https:\/\/doi.org\/10.1111\/acps.13277","journal-title":"Acta Psychiatr Scand"},{"key":"2087_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neubiorev.2020.06.017","volume":"116","author":"L Del Matto","year":"2020","unstructured":"Del Matto L, Muscas M, Murru A, Verdolini N, Anmella G, Fico G, et al. Lithium and suicide prevention in mood disorders and in the general population: a systematic review. Neurosci Biobehav Rev. 2020;116:142\u201353. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.06.017","journal-title":"Neurosci Biobehav Rev."},{"key":"2087_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jad.2021.12.047","volume":"300","author":"M Kuperberg","year":"2021","unstructured":"Kuperberg M, K\u00f6hler-Forsberg O, Shannon AP, George N, Greenebaum S, Bowden CL, et al. Cardiometabolic risk markers during mood-stabilizing treatment: correlation with drug-specific effects, depressive symptoms and treatment response. J Affect Disord. 2021;300:41\u201349. https:\/\/doi.org\/10.1016\/j.jad.2021.12.047","journal-title":"J Affect Disord."},{"key":"2087_CR6","doi-asserted-by":"publisher","unstructured":"Federoff M, McCarthy MJ, Anand A, Berrettini WH, Bertram H, Bhattacharjee A, et al. Correction of depression-associated circadian rhythm abnormalities is associated with lithium response in bipolar disorder. Bipolar Disord. 2021. https:\/\/doi.org\/10.1111\/bdi.13162.","DOI":"10.1111\/bdi.13162"},{"key":"2087_CR7","doi-asserted-by":"publisher","unstructured":"Schoretsanitis G, de Filippis R, Brady BM, Homan P, Suppes T, Kane JM. Prevalence of impaired kidney function in patients with long-term lithium treatment: a systematic review and meta-analysis. Bipolar Disord. 2021. https:\/\/doi.org\/10.1111\/bdi.13154.","DOI":"10.1111\/bdi.13154"},{"key":"2087_CR8","doi-asserted-by":"publisher","first-page":"9315","DOI":"10.3390\/ijms22179315","volume":"22","author":"R Nayak","year":"2021","unstructured":"Nayak R, Rosh I, Kustanovich I, Stern S. Mood stabilizers in psychiatric disorders and mechanisms learnt from in vitro model systems. Int J Mol Sci 2021;22:9315. https:\/\/doi.org\/10.3390\/ijms22179315","journal-title":"Int J Mol Sci"},{"key":"2087_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.neubiorev.2021.05.002","volume":"127","author":"A Khayachi","year":"2021","unstructured":"Khayachi A, Schorova L, Alda M, Rouleau GA, Milnerwood AJ. Posttranslational modifications & lithium\u2019s therapeutic effect\u2014Potential biomarkers for clinical responses in psychiatric & neurodegenerative disorders. Neurosci Biobehav Rev. 2021;127:424\u201345. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.05.002","journal-title":"Neurosci Biobehav Rev."},{"key":"2087_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/ijms22041532","volume":"22","author":"K Sakrajda","year":"2021","unstructured":"Sakrajda K, Szczepankiewicz A. Inflammation-related changes in mood disorders and the immunomodulatory role of lithium. Int J Mol Sci. 2021;22:1532. https:\/\/doi.org\/10.3390\/ijms22041532","journal-title":"Int J Mol Sci."},{"key":"2087_CR11","unstructured":"Guideline: practice guideline for the treatment of patients with bipolar disorder, second edition. 2002. https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/bipolar.pdf"},{"key":"2087_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/bdi.12543","volume":"19","author":"KA Smith","year":"2017","unstructured":"Smith KA, Cipriani A. Lithium and suicide in mood disorders: updated meta-review of the scientific literature. Bipolar Disord. 2017;19:575\u201386. https:\/\/doi.org\/10.1111\/bdi.12543","journal-title":"Bipolar Disord."},{"key":"2087_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/acps.13202","volume":"142","author":"SA Barroilhet","year":"2020","unstructured":"Barroilhet SA, Ghaemi SN. When and how to use lithium. Acta Psychiatr Scand. 2020;142:161\u201372. https:\/\/doi.org\/10.1111\/acps.13202","journal-title":"Acta Psychiatr Scand."},{"key":"2087_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jad.2020.03.030","volume":"269","author":"A Bahji","year":"2020","unstructured":"Bahji A, Ermacora D, Stephenson C, Hawken ER, Vazquez G. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis. J Affect Disord. 2020;269:154\u201384. https:\/\/doi.org\/10.1016\/j.jad.2020.03.030","journal-title":"J Affect Disord."},{"key":"2087_CR15","unstructured":"Nath M, Gupta V Mood Stabilizers. 2021. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022."},{"key":"2087_CR16","doi-asserted-by":"publisher","unstructured":"Stahl SM. Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical application. Cambridge University Press; 2021. https:\/\/doi.org\/10.1017\/9781108975292","DOI":"10.1017\/9781108975292"},{"key":"2087_CR17","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.4088\/JCP.10060tx2cc","volume":"73","author":"A Podawiltz","year":"2012","unstructured":"Podawiltz A. A review of current bipolar disorder treatment guidelines. J Clin Psychiatry. 2012;73:e12. https:\/\/doi.org\/10.4088\/JCP.10060tx2cc","journal-title":"J Clin Psychiatry"},{"key":"2087_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/bdi.13040","volume":"23","author":"N Verdolini","year":"2021","unstructured":"Verdolini N, Hidalgo-Mazzei D, Del Matto L, Muscas M, Pacchiarotti I, Murru A, et al. Long-term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms. Bipolar Disord. 2021;23:324\u201340. https:\/\/doi.org\/10.1111\/bdi.13040","journal-title":"Bipolar Disord."},{"key":"2087_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/YCO.0b013e328333e132","volume":"23","author":"KN Fountoulakis","year":"2010","unstructured":"Fountoulakis KN. An update of evidence-based treatment of bipolar depression: where do we stand? Curr Opin Psychiatry. 2010;23:19\u201324. https:\/\/doi.org\/10.1097\/YCO.0b013e328333e132","journal-title":"Curr Opin Psychiatry"},{"key":"2087_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40263-019-00688-2","volume":"34","author":"N Xu","year":"2020","unstructured":"Xu N, Huggon B, Saunders KEA. Cognitive impairment in patients with bipolar disorder: impact of pharmacological treatment. CNS Drugs. 2020;34:29\u201346. https:\/\/doi.org\/10.1007\/s40263-019-00688-2","journal-title":"CNS Drugs."},{"key":"2087_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-021-00463-2","volume":"16","author":"LD Nguyen","year":"2021","unstructured":"Nguyen LD, Fischer TT, Ehrlich BE. Pharmacological rescue of cognitive function in a mouse model of chemobrain. Mol Neurodegener. 2021;16:41. https:\/\/doi.org\/10.1186\/s13024-021-00463-2","journal-title":"Mol Neurodegener."},{"key":"2087_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuro.2020.12.016","volume":"83","author":"MA Ebeid","year":"2021","unstructured":"Ebeid MA, Habib MZ, Mohamed AM, Faramawy YE, Saad SST, El-Kharashi OA, et al. Cognitive effects of the GSK-3 inhibitor \u201clithium\u201d in LPS\/chronic mild stress rat model of depression: Hippocampal and cortical neuroinflammation and tauopathy. Neurotoxicology. 2021;83:77\u201388. https:\/\/doi.org\/10.1016\/j.neuro.2020.12.016","journal-title":"Neurotoxicology."},{"key":"2087_CR23","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/s41386-020-0683-2","volume":"45","author":"KE Burdick","year":"2020","unstructured":"Burdick KE, Millett CE, Russo M, Alda M, Alliey-Rodriguez N, Anand A, et al. The association between lithium use and neurocognitive performance in patients with bipolar disorder. Neuropsychopharmacology. 2020;45:1743\u20139. https:\/\/doi.org\/10.1038\/s41386-020-0683-2","journal-title":"Neuropsychopharmacology"},{"key":"2087_CR24","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1017\/S0033291719004112","volume":"51","author":"F Hozer","year":"2021","unstructured":"Hozer F, Sarrazin S, Laidi C, Favre P, Pauling M, Cannon D, et al. Lithium prevents grey matter atrophy in patients with bipolar disorder: An international multicenter study. Psychol Med. 2021;51:1201\u201310. https:\/\/doi.org\/10.1017\/S0033291719004112","journal-title":"Psychol Med."},{"key":"2087_CR25","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1021\/acscentsci.1c00843","volume":"7","author":"CE McGhee","year":"2021","unstructured":"McGhee CE, Yang Z, Guo W, Wu Y, Lyu M, DeLong CJ, et al. DNAzyme-based lithium-selective imaging reveals higher lithium accumulation in bipolar disorder patient-derived neurons. ACS Cent Sci. 2021;7:1809\u201320. https:\/\/doi.org\/10.1021\/acscentsci.1c00843","journal-title":"ACS Cent Sci."},{"key":"2087_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jad.2017.10.019","volume":"227","author":"W Liu","year":"2018","unstructured":"Liu W, Xue X, Xia J, Liu J, Qi Z. Swimming exercise reverses CUMS-induced changes in depression-like behaviors and hippocampal plasticity-related proteins. J Affect Disord. 2018;227:126\u201335.","journal-title":"J Affect Disord"},{"key":"2087_CR27","doi-asserted-by":"crossref","unstructured":"Can A, Dao DT, Arad M, Terrillion CE, Piantadosi SC, Gould TD. The mouse forced swim test. J Vis Exp. 2012:e3638.","DOI":"10.3791\/3638"},{"key":"2087_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01750-8","volume":"11","author":"M Chen","year":"2021","unstructured":"Chen M, Tian H, Huang G, Fang T, Lin X, Shan J, et al. Calcium imaging reveals depressive- and manic-phase-specific brain neural activity patterns in a murine model of bipolar disorder: a pilot study. Transl Psychiatry. 2021;11:619. https:\/\/doi.org\/10.1038\/s41398-021-01750-8","journal-title":"Transl Psychiatry"},{"key":"2087_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.85","volume":"7","author":"LA Feldcamp","year":"2017","unstructured":"Feldcamp LA, Boutros PC, Raymond R, Fletcher PJ, Nobrega JN, Wong AHC. Pdxdc1 modulates prepulse inhibition of acoustic startle in the mouse. Transl Psychiatry. 2017;7:e1125.","journal-title":"Transl Psychiatry"},{"key":"2087_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nm.4274","volume":"23","author":"F Koukouli","year":"2017","unstructured":"Koukouli F, Rooy M, Tziotis D, Sailor KA, O\u2019Neill HC, Levenga J, et al. Nicotine reverses hypofrontality in animal models of addiction and schizophrenia. Nat Med. 2017;23:347\u201354. https:\/\/doi.org\/10.1038\/nm.4274","journal-title":"Nat Med."},{"key":"2087_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2147\/NDT.S126708","volume":"13","author":"P De Fazio","year":"2017","unstructured":"De Fazio P, Gaetano R, Caroleo M, Pavia M, De Sarro G, Fagiolini A, et al. Lithium in late-life mania: a systematic review. Neuropsychiatr Dis Treat. 2017;13:755\u201366. https:\/\/doi.org\/10.2147\/NDT.S126708","journal-title":"Neuropsychiatr Dis Treat."},{"key":"2087_CR32","doi-asserted-by":"publisher","first-page":"CD004048","DOI":"10.1002\/14651858.CD004048.pub4","volume":"6","author":"RF McKnight","year":"2019","unstructured":"McKnight RF, de La Motte de Bro\u00f6ns de Vauvert SJGN, Chesney E, Amit BH, Geddes J, Cipriani A. Lithium for acute mania. Cochrane Database Syst Rev. 2019;6:CD004048. https:\/\/doi.org\/10.1002\/14651858.CD004048.pub4","journal-title":"Cochrane Database Syst Rev."},{"key":"2087_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-2006-931471","volume":"39","author":"K Masmoudi","year":"2006","unstructured":"Masmoudi K, Gras-Champel V, Masson H, Andr\u00e9jak M. Parkinsonism and\/or cognitive impairment with valproic acid therapy: a report of ten cases. Pharmacopsychiatry. 2006;39:9\u201312. https:\/\/doi.org\/10.1055\/s-2006-931471","journal-title":"Pharmacopsychiatry."},{"key":"2087_CR34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/npr2.12181","volume":"41","author":"M Ito","year":"2021","unstructured":"Ito M, Kinjo T, Seki T, Horie J, Suzuki T. The long-term prognosis of hippocampal neurogenesis and behavioral changes of offspring from rats exposed to valproic acid during pregnancy. Neuropsychopharmacol Rep. 2021;41:260\u20134. https:\/\/doi.org\/10.1002\/npr2.12181","journal-title":"Neuropsychopharmacol Rep."},{"key":"2087_CR35","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.2147\/NDT.S256117","volume":"16","author":"RM El Sabaa","year":"2020","unstructured":"El Sabaa RM, Hamdi E, Hamdy NA, Sarhan HA. Effects of levetiracetam compared to valproate on cognitive functions of patients with epilepsy. Neuropsychiatr Dis Treat. 2020;16:1945\u201353. https:\/\/doi.org\/10.2147\/NDT.S256117","journal-title":"Neuropsychiatr Dis Treat."},{"key":"2087_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms23010023","volume":"23","author":"A Song","year":"2021","unstructured":"Song A, Cho GW, Vijayakumar KA, Moon C, Ang MJ, Kim J, et al. Neuroprotective effect of valproic acid on salicylate-induced tinnitus. Int J Mol Sci. 2021;23:23. https:\/\/doi.org\/10.3390\/ijms23010023","journal-title":"Int J Mol Sci."},{"key":"2087_CR37","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","volume":"360","author":"KJ Meador","year":"2009","unstructured":"Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360:1597\u2013605. https:\/\/doi.org\/10.1056\/NEJMoa0803531","journal-title":"N Engl J Med."},{"key":"2087_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.genhosppsych.2019.05.005","volume":"59","author":"B Duman","year":"2019","unstructured":"Duman B, Can KC, A\u011fta\u015f-Ertan E, Erdo\u011fan S, \u0130lhan RS, Do\u011fan \u00d6, et al. Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions. Gen Hosp Psychiatry. 2019;59:67\u201372. https:\/\/doi.org\/10.1016\/j.genhosppsych.2019.05.005","journal-title":"Gen Hosp Psychiatry"},{"key":"2087_CR39","doi-asserted-by":"publisher","first-page":"111322","DOI":"10.1016\/j.biopha.2021.111322","volume":"137","author":"A Taleb","year":"2021","unstructured":"Taleb A, Lin W, Xu X, Zhang G, Zhou QG, Naveed M, et al. Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment. Biomed Pharmacother. 2021;137:111322. https:\/\/doi.org\/10.1016\/j.biopha.2021.111322","journal-title":"Biomed Pharmacother."},{"key":"2087_CR40","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1212\/WNL.0b013e31820d62c7","volume":"76","author":"C Nadebaum","year":"2011","unstructured":"Nadebaum C, Anderson VA, Vajda F, Reutens DC, Barton S, Wood AG. Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology. 2011;76:719\u201326. https:\/\/doi.org\/10.1212\/WNL.0b013e31820d62c7","journal-title":"Neurology."},{"key":"2087_CR41","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/bmj.f3646","volume":"27","author":"A Cipriani","year":"2013","unstructured":"Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;27:346. https:\/\/doi.org\/10.1136\/bmj.f3646","journal-title":"BMJ."},{"key":"2087_CR42","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1192\/bjp.158.5.666","volume":"158","author":"FG Souza","year":"1991","unstructured":"Souza FG, Goodwin GM. Lithium treatment and prophylaxis in unipolar depression: a meta-analysis. Br J Psychiatry. 1991;158:666\u201375.","journal-title":"Br J Psychiatry."},{"key":"2087_CR43","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1176\/ajp.2006.163.9.1519","volume":"163","author":"AA Nierenberg","year":"2006","unstructured":"Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry. 2006;163:1519\u201330.","journal-title":"Am J Psychiatry."},{"key":"2087_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1055\/s-2007-979581","volume":"28","author":"A Nilsson","year":"1995","unstructured":"Nilsson A. Mortality in recurrent mood disorders during periods on and off lithium\u2014a complete population study in 362 patients. Pharmacopsychiatry. 1995;28:8\u201313.","journal-title":"Pharmacopsychiatry."},{"key":"2087_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jagp.2021.04.014","volume":"30","author":"DP Devanand","year":"2022","unstructured":"Devanand DP, Crocco E, Forester BP, Husain MM, Lee S, Vahia IV, et al. Low dose lithium treatment of behavioral complications in Alzheimer\u2019s disease: Lit-AD randomized clinical trial. Am J Geriatr Psychiatry. 2022;30:32\u201342. https:\/\/doi.org\/10.1016\/j.jagp.2021.04.014","journal-title":"Am J Geriatr Psychiatry."},{"key":"2087_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-020-00188-z","volume":"8","author":"C Baethge","year":"2020","unstructured":"Baethge C. Low-dose lithium against dementia. Int J Bipolar Disord. 2020;8:25. https:\/\/doi.org\/10.1186\/s40345-020-00188-z","journal-title":"Int J Bipolar Disord."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02087-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02087-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02087-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T08:03:42Z","timestamp":1662105822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02087-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2087"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02087-6","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"15 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"359"}}